As a result of NED, PCa cells exhibit a reduced expression of luminal lineage markers such as AR and PSA coupled with increased expression of alternative neuroendocrine (NE) lineage markers such as enolase 2 (ENO2), chromogranin A (CHGA) and synaptophysin (SYP) [8,9]. The gene discussed is AR; the disease is posterior cortical atrophy.